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Abstract
We introduce and analyze a within-host dynamical model of the coevolution between rapidly mutating
pathogens and the adaptive immune response. Pathogen mutation and a homeostatic constraint on lym-
phocytes both play a role in allowing the development of chronic infection, rather than quick pathogen
clearance. The dynamics of these chronic infections display emergent structure, including branching pat-
terns corresponding to asexual pathogen speciation, which is fundamentally driven by the coevolutionary
interaction. Over time, continued branching creates an increasingly fragile immune system, and leads to
the eventual catastrophic loss of immune control.
Introduction
The immune system is a complex adaptive system whose richness makes it an excellent model for nonlinear
dynamics and biological complexity. From the basic physical and chemical interactions between foreign
substances and the body’s repertoire of lymphocytes, an array of complex system-wide behaviors can
arise as the immune system works to recognize and eliminate harmful pathogens [1]. The development of
immune system models has helped to identify mechanisms that underlie many of these emergent behaviors
(e.g. [2–9]).
The adaptive immune system of vertebrates has the remarkable ability to discriminate between self
and non-self agents in the body, and to remove the foreign threats when recognized. The system consists
of a complex array of lymphocytes, or white blood cells, which are able to recognize foreign agents
with the high binding specificity of their receptors. These receptors are assembled randomly from gene
segments in the bone marrow, and those that bind to the body’s own cells are negatively selected as
the lymphocytes mature in the thymus. The population of mature cells in the lymph nodes then has
a diverse collection of specifically shaped receptors that can bind with high affinity to complementary
peptide sequences, called epitopes, on many possible types of foreign antigen [1]. During an infection,
lymphocytes that successfully bind with antigen rapidly proliferate to build an immune response that
specifically targets the bound antigen for clearance.
During the course of an infection, mutations that alter the shape, charge, or hydrophobicity of epi-
topes can impair continued recognition of the infection by the initially stimulated lymphocytes [10, 11].
Some rapidly mutating pathogens, most notably HIV, use this strategy to avoid clearance by the initial
immune response and develop into a chronic infection [1,3,12]. The adaptive immune system must then
continuously adapt to control new mutant pathogen strains. This control can be aided by cross-reactivity:
lymphocytes that bind strongly to one epitope can also bind with lower affinity to similarly shaped epi-
topes [13,14]. Thus, a mutant with similar binding characteristics to the originally recognized epitope can
be partially controlled by the existing immune response until a more specific response is stimulated [3,15].
However, competition between lymphocytes, which during an infection swell to densities above the ideal
homeostatic level, can also impair the overall immune response [6]. These dynamics of pathogen mutation
and lymphocyte adaptation can be important in determining the eventual outcome of an infection.
In this paper, we introduce a new model of this coevolution between the adaptive immune response
and mutating pathogens. The model abstracts the chemical and molecular details of the binding interac-
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2tion, while retaining important features that affect infection dynamics. We account for cross-reactivity by
representing these populations on a phenotypic shape space, in which the distance separating a pathogen
and lymphocyte pair maps to a particular binding affinity (in general, larger distances give lower affini-
ties). This method has been used in theoretical studies of immune system characteristics and behaviors
affected by cross-reactivity, such as clonal repertoire size, self-nonself discrimination [16], and immunose-
nescence [17]. We focus on the characteristics of T-cells, lymphocytes that form the primary response to
certain rapidly mutating viruses such as HIV [18].
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Figure 1. Coevolving shape space distributions of pathogen and T-cell populations over
900 days of infection. The infection shown is an example of a stochastic mutating infection. Inset A
(days 0-50) highlights the early periodic bursts of pathogen mutation which lead to chronic infection
rather than clearance, driven by peaks in pathogen density which are subsequently controlled by the
immune response. Insets B and C (days 50-500) provide a closer look at the chronic phase, which
exhibits wave-like pathogen dynamics, pathogen speciation driven by the interaction with the immune
response, and a resulting branch in T-cells, which is caused by selection alone. Following more
branching, increased homeostatic pressure on the T-cells leads to the pathogens’ dramatic escape from
immune control (around day 870), marked by sudden rapid proliferation and unchecked diffusion
throughout shape space. In this simulation, λ = 3.3 day−1, b = 10 sites, Γ = 4 (µl · site · day)−1,
ξ = 2.3× 10−3 day−1, δ = 0.35 day−1, and all other parameters are given in Table 1.
In a rapidly mutating infection, the interactions we model give rise to complex dynamics. We observe
several qualitatively different possible outcomes of infection, including early pathogen clearance, early
pathogen escape, and the development of a long-lasting chronic infection. We also show the emergence
of complex structure from the dynamics of a single chronic infection, including branching patterns in
the pathogen population (Fig. 1). In this evolutionary branching a unimodal phenotypic distribution of
pathogens splits into two distinct and independently evolving clusters [19]. This is analogous to asexual
symptaric speciation [20] and arises naturally from the coevolutionary interaction between pathogens
and T-cells. Although this speciation initially occurs while the infection is well-controlled, the numbers
of lymphocytes needed to control the increasing number of distinct pathogen strains eventually exceeds
3the homeostatic constraints. This results in a sudden breakdown of immune control and a dramatic
pathogenic escape, also visible in Fig. 1.
Methods
To capture binding region diversity in the pathogen and T-cell populations, we describe them as densities
denoted by P (~x, t) and L(~y, t) respectively [14,17]. The vectors ~x and ~y denote positions in a shape space
of phenotypes which determine the binding affinity γ(~x, ~y) between pathogens and T-cells [16]. There
is maximal binding complementarity when ~x = ~y, and monotonically decreasing affinity with increasing
distance |~x − ~y| between T-cell and pathogen. Following previous theoretical work [14, 17, 21], we take
this decay to be Gaussian:
γ(~x, ~y) = exp
[
−|~x− ~y|
2
2b2
]
. (1)
The parameter b sets the specificity of antigen recognition and thus the length scale of the space. We
do not consider the possibility of multiple epitopes, but identify each pathogen with a single shape space
location.
The binding affinity mediates all interactions between pathogens and T-cells. The stimulation of
T-cells by pathogens is modeled as a saturating function [22] of pathogen density and proximity in shape
space, a multiplicative factor ranging from zero to one:
Psat(~y, t) =
∫
γ(~x, ~y)P (~x, t)d~x
κ+
∫
γ(~x, ~y)P (~x, t)d~x
∈ [0, 1]. (2)
There can be equivalent stimulation from low-density but high-affinity, high-density but low-affinity, or
a combination of such pathogen distributions. If Psat(~y, t) is high, T-cells at ~y are stimulated to divide
and their decay is suppressed, generating an immune response.
The killing of pathogens by T-cells is also a function of the affinity: the total killing rate of P (~x, t) is
proportional to the effectivity,
Ω(~x, t) =
∫
γ(~x, ~y)L(~y, t)d~y, (3)
a measure of the quality of an immune response [14].
The following coupled differential equations describe pathogen and T-cell dynamics:
dL(~y, t)
dt
= Γ + ξ
[
1− Ltot(t)
R
]
L(~y, t) + σPsat(~y, t)L(~y, t)− δ [1− Psat(~y, t)]L(~y, t); (4)
dP (~x, t)
dt
=
[
1− Ptot(t)
φ
] ∫
λ(~x′)P (~x′, t)Q(~x′, ~x)d~x′ − βP (~x, t)Ω(~x, t). (5)
The first term of Eq. (4) represents a constant influx Γ of na¨ıve T-cells from the bone marrow or
thymus. The second term, describing logistic growth, accounts for homeostatic competition between
all T-cells [23, 24], independent of binding characteristics. This allows proliferation under lymphopenic
conditions, and decay when the total T-cell density Ltot(t) =
∫
L(~y, t) d~y is above the carrying capacity
R, as is usually the case during response to an infection. The third term of Eq. (4) describes T-cell
proliferation in response to stimulation by pathogens; this occurs at rate σ×Psat(~y, t), which falls between
0 and σ depending on the pathogen population surrounding ~y. T-cells turn over at rate δ (fourth term
of Eq. (4)), but in activated T-cells this turnover is suppressed by the factor of (1− Psat).
In the absence of immune response (i.e. Ω = 0), Eq. (5) describes pathogens proliferating at rate
λ(~x). We account for a fitness landscape for the pathogens (independent of immune pressure) by making
4this rate a function of ~x. Since all pathogens compete for the same resources, we include a logistic
factor in the first term of Eq. (5), limiting growth of any individual strain as the total pathogen density
Ptot(t) =
∫
P (~x, t) d~x approaches a capacity φ. It has been shown that target cell models for viral
dynamics reduce to a logistic equation [25].
Table 1. Parameters used in all simulations unless otherwise noted. Values are approximated within
biologically relevant ranges, based on known immune system characteristics and previous modeling
work [8, 14] (see Appendix S1 for details). Although the exact phase diagram boundaries between
regions with different infection outcomes may change at different parameter values, the qualitative
dynamics within each infection outcome are not especially sensitive to the exact values of these
parameters.
Parameter Sym. Value
pathogen mutation rate µ 2.2× 10−5 (base · cycle)−1
binding specificity b 20 sites
pathogen growth λ 3 day−1
pathogen capacity φ 1010 µl−1
pathogen killing β 10−5 µl · day−1
na¨ıve cell influx Γ 1 (µl · site · day)−1
homeostatic pressure ξ 6.1× 10−4 day−1
T-cell replication σ 3 day−1
T-cell decay δ 0.33 day−1
stimulation coefficient κ 105 µl−1
We incorporate mutation into the logistic growth law of Eq. (5) with a mutation kernel Q [3]. The
matrix element Q(~x, ~x′) gives the mutation rate of a pathogen from shape space location ~x to location
~x′, as a fraction of the replication rate λ(~x). This mutation conserves pathogen number:∫
Q(~x, ~x′)d~x′ = 1, ∀ ~x. (6)
In this study, we choose a decaying kernel, so that the mutation rate between two different sites falls
off as distance between the sites increases:
Q(~x, ~x′) =
(
2
pi
) 1
2
χ|~x− ~x′|−2, ∀ ~x 6= ~x′. (7)
Mutations to nearby sites are thus much more likely than long-distance ones, but long-distance mutations
still occur at a non-negligible rate, due to the possibility that a single amino acid substitution may
substantially change the charge or hydrophobicity of an entire binding region. Finally, for our simulation
lattice of n sites, we choose χ so that the total fraction of pathogen at ~x that mutates to any different
site ~x′ 6= ~x sums to the overall pathogen mutation rate µ:∑
~x′ 6=~x
Q(~x, ~x′) = µ, ∀ ~x. (8)
In order to understand the roles of particular parameters in the outcome of these infections, we
represent the process as deterministic. We can also extend this to a stochastic model by shuffling the
kernel, generating new set of rates Q(~x, ~x′) at regular intervals of 0.1 days. To do this, we draw a rate
for each ~x 6= ~x′ from a folded normal distribution with standard deviation χ|~x− ~x′|−2, and set the rates
for ~x = ~x′ to satisfy Eq. (6). The series of kernels generated has a time average equal to the original
5kernel. Although in this study we focus mainly on the deterministic model, we include some results of
this stochastic generalization, which are explicitly noted when presented.
Our simulations are performed on a one-dimensional lattice with n = 400 sites. We hold pathogen
fitness λ(~x) constant across shape space, except at the edges of the lattice where it converges to zero to
prevent edge effects. The population density at any site is automatically set to zero upon falling below a
threshold of 1 to prevent unrealistic dynamics resulting from arbitrarily low densities. Parameter values
are provided in Table 1; further information about the estimation of these parameters is provided in
Appendix S1.
Results
Before it is inoculated with pathogens, the immune system is at rest at homeostatic equilibrium. The
corresponding steady-state solution with no pathogens in the system is a uniform distribution of T-cells
across shape space, which models well the random distribution of na¨ıve cells before exposure to infection:
P ∗(~x) = 0, ∀ ~x; L∗(~y) = R
2n
(1− δ
ξ
)
+
√(
1− δ
ξ
)2
+
4nΓ
Rξ
 , ∀ ~y. (9)
We choose the carrying capacity R to equal the total equilibrium population of T-cells (R = n×L∗(~y)).
This results in the simpler steady-state solution which we use for our initial condition:
P ∗(~x) = 0, ∀ ~x; L∗(~y) = Γ
δ
, ∀ ~y. (10)
This pathogen solution is not stable, but we assume that a scenario with no pathogens in the system
exists before inoculation. During an infection, the presence in our model of a threshold population density
below which all pathogen populations are assumed to be 0 allows total clearance to occur. The T-cell
solution is a stable attractor: as long as no pathogens exist in the system, the T-cells will converge to
carrying capacity R = Γn/δ with naive cells uniformly distributed through shape space.
During an infection, however, the T-cell population must be elevated above carrying capacity for some
amount of time to establish control over the pathogens. The cost of this growth of the T-cell population
above homeostatic equilibrium is a slow decay of T-cells across all of shape space, at a rate proportional
to the amount by which the population exceeds the equilibrium. This reduces both the growth rate of
stimulated T-cells and the diversity of the overall T-cell population, and can severely compromise the
immune system’s ability to control an infection.
At time t = 0, we inoculate our system with a small, localized dose of pathogens at site ~x0. Since
the initial dose grows exponentially until large enough to either (a) stimulate the immune response, (b)
produce viable mutant strains, and/or (c) near its own carrying capacity, the exact size of the dose does
not qualitatively affect the trajectory of the infection, as long as it is small enough to avoid triggering
these processes initially. We use the value P (~x0, t = 0) = 10 µl
−1.
Over a range of biologically reasonable parameter values, we find that there are four possible qualita-
tively distinct trajectories that a single infection may take (depicted in Fig. 2):
(1) In regions of parameter space where Ω(~x0, t = 0) > λ/β, the pathogen population decays immedi-
ately upon introduction to the system, an outcome known as sterilizing immunity. In this paper,
we focus on infections well outside of these regions, and this outcome is not shown in Fig. 2.
(2) Also possible is early clearance, in which the pathogen population initially grows exponentially but
is completely cleared before reaching a steady-state level (Fig. 2A).
6(3) In some regions of parameter space, an infection is able to escape early clearance, often by mutating
to establish itself in shape space locations outside the reach of the initial immune response. These
infections then approach an approximate steady state, where the pathogens coexist with the immune
response at a controlled level in a localized region of shape space for an extended amount of time,
which we term a chronic infection (see Fig. 2B). A chronic infection may also include mutations,
leading to the antigenic drift of the localized pathogen population.
(4) Finally, the pathogens may avoid not only early clearance, but also any lasting localization or
reduction of their population by the immune response (see Fig. 2C). These early escape infections
grow to carrying capacity or fill the entire shape space before the immune system can establish
control.
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Figure 2. Examples of three of the four distinct types of infection observed in the
deterministic model. (The case of sterilizing immunity is not shown.) The total population densities
of both pathogens and T-cells (top panels), as well as the shape space distribution of the pathogens
(bottom panels), are plotted over time for each infection. A. Early clearance after the acute phase of
infection (µ = 1× 10−5 (base · cycle)−1, b = 36sites). B. Chronic infection in which mutant pathogen
strains avoid clearance by the initial immune response (µ = 2.5× 10−5 (base · cycle)−1, b = 32 sites).
The first 50 days, in which this initial avoidance occurs, are shown on the left; on the right (days 50 -
500), the total pathogen density remains nearly constant while slow antigenic drift and branching occur.
C. Early escape (µ = 3× 10−5 (base · cycle)−1, b = 24 sites). Some pathogens are cleared by the initial
immune response, but the population reaches carrying capacity without being controlled. Parameter
values in Table 1 were used unless otherwise noted.
Development of Chronic Infection: Role of Pathogen Mutation and Immune
Trade-offs
With these initial conditions, the system undergoes dynamics corresponding to the acute phase of infec-
tion: roughly exponential growth of pathogens until the T-cells are stimulated, followed by the growth
of T-cells until the pathogen population begins to decay. Examples for both mutating and non-mutating
infections during this phase (days 0-50) are shown in Fig. 3. Any system trajectory which eventually
7brings the pathogen population at all sites below the threshold – for example, the black dotted curve in
Fig. 3B – will lead to total pathogen clearance, and a subsequent return of the system to the equilibrium
state in Eq. (10). This occurs in the non-mutating infection in Fig. 3A, where pathogens are cleared
about a week after inoculation.
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Figure 3. Coevolutionary dynamics in the first 50 days of infection. Shown here are the
mutating infection from Fig. 1 and a non-mutating infection with the same parameter values. A. Plots
of total pathogen and total T-cell populations for both non-mutating (dashed) and mutating infections
(solid curves). When there is no mutation, the pathogen density decays below the threshold and is set
to zero. With mutation, pathogens escape clearance as strains arise with lower affinity to the T-cell
response (see Fig. 1A). Both pathogens and T-cells then converge to an approximate equilibrium state
corresponding to a chronic infection. The inset shows total mutating pathogen density for the entire
900-day infection, which displays qualitative features observed in HIV and SIV [31]; peaks in the
chronic phase correspond to branching events (see Fig. 1). B. Phase plot of total T-cell versus total
pathogen densities for the first 50 days of the two simulated infections in A and a third infection with a
higher initial dose of pathogens. Of the low-dose infections, only the mutating case escapes clearance,
converging to a chronic state similar to the approximate steady state (Eq. 12) existing in the
non-mutating system. Parameters are given in Table 1.
The mutating pathogens in Fig. 3A, however, with the same initial conditions and the same system
parameters except for mutation rate, are able to avoid early clearance by generating new strains with low
affinity to the initial immune response. (These strains are visible in Figs. 2B and 1A.) This allows the
T-cell and pathogen densities to converge to a chronic infection, an approximate equilibrium at which
T-cells coexist with a controlled, localized pathogen population.
The corresponding steady-state solution can be approximated from our equations in the case of non-
mutating pathogens localized at a single site ~x0. With the assumption that the T-cell population is large
enough early in the infection that the influx Γ is negligible, the pathogen population’s steady-state value
in the non-mutating system is
P ∗(~x0) ≈ κ(δ − ξ(1− Ltot/R))
σ + ξ(1− Ltot/R) . (11)
The terms beginning with ξ in the numerator and denominator of Eq. 11 are negligible in estimating the
steady state as long as σR/ξ >> |Ltot − R| and δR/ξ >> |Ltot − R|, which is a good approximation
for all infections in this study. In the simplest case, where we assume the T-cells are also localized at
8a single shape space site ~y0 in order to approximate the narrow peaks they form under the homeostatic
constraint, we find for the non-mutating case that
P ∗(~x0) ≈ κδ/σ; L∗(~y0) ≈ λ/β. (12)
In non-mutating systems, this approximate steady state occurs with appropriate initial conditions,
such as a large initial pathogen dose (solid green curve in Fig. 3B). It is also quite similar to the chronic
state reached by the mutating infection. Fig. 3B shows the system trajectory for this mutating infection
(solid black curve) through day 50, in comparison with two trajectories of the non-mutating infection
(solid green curve and dashed black curve). This infection is a typical example of the valuable strategy of
mutation allowing pathogens that would otherwise be cleared in small-dose initial conditions – e.g. the
example infection in Fig. 3 – to avoid clearance (Eq. 10) and converge to a chronic infection (Eq. 12).
The population density distribution of the pathogens during this process is shown in Fig. 1A. The
pathogens remain at their original location until the population nears its peak density, at which point
several new strains arise farther from the control of the responding T-cells. It is these partial escape muta-
tions which allow the resurgence of total pathogen density seen in Fig. 3A just before day 10. Subsequent
pathogen peaks in Fig. 3A each have lower density, and Fig. 1A shows that each of these successive peaks
results in a decreased mutation distance in shape space. Because longer-distance mutations occur at
lower rates, higher pathogen densities are required for them to occur.
Since pathogen mutation can allow infections that would otherwise be cleared to become chronic
if they can establish strains with low affinity to the initial immune response, we would expect greater
success for pathogens with higher mutation rates, which are able to generate longer-distance mutations.
Similarly, we would expect greater success for pathogens that face more specific immune responses, since
they have a smaller range of T-cell recognition to evade. While these expectations are often borne out,
our results also show deviations from this behavior, which are determined by both the underdamped
oscillatory nature of the early-infection population dynamics and the strength of the resource constraint
on the immune system.
We examine the dynamics as a function of µ, the pathogen mutation rate, and b, the width of the
T-cells anity curve, at two different values of the homeostatic strength parameter ξ. Fig. 4 shows a
phase diagram of system trajectories at a relatively low homeostatic pressure ξ. In most cases, our
simple expectation is confirmed: infections with higher mutation rates and those that face more specific
immune responses are those that become chronic rather than being cleared; and as µ grows and b shrinks,
the immune system becomes unable to control the pathogens at all. However, the details of the early-
infection dynamics also give rise to a trade-off: to become chronic at a given immune system specificity,
the infection needs a mutation rate both high enough to generate mutants out of the range of the initial
immune response, and low enough to avoid stimulating too strong a secondary response.
This trade-off is apparent in the thin green band of clearance amid chronic infection outcomes in
Fig. 4. The pathogens are best able to become chronic when their mutation rate allows them to expand
just far enough from the original strain to avoid being cleared (Fig. 4B); the secondary immune response
to these few surviving pathogens cells is too small to reduce them below the threshold, so the secondary
T-cell and pathogen peaks converge to a chronic infection. At higher pathogen mutation rates, however,
more mutants survive the original immune response; this can stimulate the secondary response strongly
enough that it clears the secondary pathogen peak completely (Fig. 4C), creating an isolated clearance
band. At even higher mutation rates and narrower immune specificity ranges, the secondary pathogen
peak is able to produce enough mutants of its own before being cleared to perpetuate the infection further
(Fig. 4D).
The boundaries of these phase space regions depend in complex ways on the two evolving population
distributions and on the dynamics of their interaction. In particular, boundaries between chronic infection
and clearance, such as those creating the narrow clearance band in Fig. 4, occur at phase space locations
at which, at any point in time, the maximum single-site pathogen population density reaches the constant
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Figure 4. Phase diagram of deterministic infection trajectories under low homeostatic
pressure, as a function of mutation rate µ and T-cell specificity range b. In most cases,
infections with a higher mutation rate in systems with narrower immune specificity range (i.e. higher µ
and lower b) are more successful at avoiding early clearance, but a band of cleared infections in the
otherwise chronic regime highlights a trade-off: pathogen must mutate fast enough to evade an existing
immune response, while keeping mutant numbers low enough to avoid stimulating another. A. Shape
space distribution of pathogen infection with a low mutation rate: the original inoculation and all
mutants are killed by the initial immune response. B. A faster mutation rate and narrower immune
response allows pathogen mutants to avoid the initial immune response and establish a chronic
infection. C. As mutation rate increases and specificity range narrows, an increased number of
pathogens avoid the initial immune response; this stimulates a more effective secondary response, which
is able to clear the entire mutant population. D. Chronic infection is established at a higher mutation
rate when the secondary pathogen peak is able to establish mutants that can evade the secondary
immune response. All infections have ξ = 6.7× 10−5 day−1; other parameters are given in Table 1.
minimum pathogen threshold. If the maximum single-site density falls below the threshold at any time,
the pathogen will be cleared everywhere; if it remains above the threshold at all times, the infection
will survive. This threshold is most likely to be crossed near a minimum of total pathogen density; for
example, reaching the threshold at the local pathogen density minimum following the primary (secondary)
infection peak (see Fig. 3A) corresponds to clearance by the primary (secondary) immune response, as
shown in Fig. 4B (D). At the low value of ξ used in Fig. 4, the infections in the green clearance band,
including 4C, escape the first response and succumb to the second.
At the relatively low homeostatic pressure strength used in Fig. 4 (ξ = 6.7 × 10−5 day−1), chronic
infections’ convergence to equilibrium typically takes several hundred days, with sustained oscillations
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Figure 5. Phase diagram of deterministic infection trajectories under high homeostatic
pressure. Relative to Fig. 4, this increased pressure (ξ = 6.1× 10−4 day−1 for all infections in the
main phase diagram) has the overall effect of suppressing the immune response, allowing early escape
and chronic infection to occur at lower pathogen mutation rates (µ) and larger affinity ranges (b). In
addition, as shown in the insets, convergence to the approximate steady state of chronic infection occurs
much more quickly under high homeostatic pressure (inset A), due to the damping effect of the
homeostatic constraint on population oscillations. Inset B shows population densities for an infection
with low homeostatic pressure from Fig. 4D; these display stronger, more sustained oscillations. Inset A
and infection A have µ = 2.5× 10−5 (base · cycle)−1 and b = 32 sites. Inset B and its corresponding
infection in Fig. 4D have ξ = 6.7× 10−5 day−1, µ = 2.2× 10−5 (base · cycle)−1, and b = 28 sites. All
other parameter values are specified in Table 1.
in both populations (see Figs. 4B, 4D, and 5B). The effects of increased homeostatic pressure (ξ =
6.1 × 10−4 day−1) are shown in Fig. 5. Here the resource constraint, although still a small effect in
comparison to other immune system interactions, has a significant damping effect on the oscillations in
the early-infection population dynamics, reducing the time for infections to converge the approximate
chronic steady state (Fig. 5A). These smaller oscillations keep the minimum population densities higher,
impairing the immune system’s ability to clear the pathogen population below its threshold. (Note that
in reality stochastic effects, rather than a deterministic threshold, would determine the fate of a very
small population; the values of µ and b would merely determine the probability of pathogen extinction.)
Increased homeostatic pressure thus lowers the effectiveness of the overall immune response, allowing early
escape and chronic infection to occur at lower pathogen mutation rates (µ) and larger affinity ranges (b).
In the crucial early stages of the infection that decide whether a rapid mutator will be fully cleared or
converge to a chronic infection which may later do much more damage, the level of specificity in T-cell
binding and the effect of the immune system’s resource constraint can make a significant difference.
Once chronic infection is reached, increased homeostatic pressure accelerates the narrowing of T-
cell distribution by stimulating faster decay for all T-cells; this allows pathogen branching and eventual
immune escape to occur much more quickly, in hundreds rather than thousands of days. Otherwise,
the mechanisms leading to these chronic infection behaviors are similar at different values of ξ. For
computational efficiency and easier visualization, the infections shown in Figs. 1, 2, and 3 thus use
this higher homeostatic pressure; however, the discussion of branching and escape behaviors applies to
11
infections over a range of these values.
Chronic Infection Dynamics
The chronic infection state that arises in a large class of infections displays particularly interesting dy-
namics, including instances of antigenic drift, evolutionary branching corresponding to asexual speciation
of the pathogen population, and the eventual dramatic escape of the pathogens from immune system
control.
Throughout the chronic phase, both the mutation and high-dose no-mutation simulations show control
of the pathogen population (without clearance) by the adaptive immune system. It has been suggested
that chronic infections are more often controlled by innate immunity or resource constraints (both are
well modeled by the carrying capacity term in Eq. (5)), and that T-lymphocytes take on an unresponsive
“exhausted” phenotype [25]. However, it has recently been shown that HIV is an example of a chronic
infection that is controlled by the adaptive immune system [26], and other infectious diseases with immune
evasion strategies may have similar dynamics.
Antigenic drift
Initially, peaks in pathogen density drive bursts of mutation, but when the chronic phase is reached the
evolution rate declines and stabilizes, as pathogen density converges to a near-constant level Ptot ≈ δκ/σ.
As long as the pathogen population at its peak remains large enough, however, some mutants are still
spawned very near in shape space to the pathogen peak, and those further from the existing immune
response have a competitive advantage. This results in a gradual traveling wave of pathogens in the
phenotypic space, shown in Fig. 1C. This type of motion through a one-dimensional fitness space has
been seen in analytical studies of related models, including the specific situation of antigenic drift in RNA
viruses [27], and a pathogen’s interaction with a traveling adaptive immune response [4].
The corresponding T-cell dynamics in Fig. 1 are purely the result of selection (we have ignored
mutation of lymphocyte receptors, a choice more consistent with T-cell dynamics [28]). Thus, wave-like
motion driven by the interplay between mutation and selection does not appear. Instead, a constantly
maintained low density of unactivated cells across shape space allows T-cells to peak wherever they
are most highly stimulated, while homeostatic pressure keeps these peaks narrow by causing formerly
stimulated T-cells to decay. The decay of formerly stimulated T-cells during a chronic infection scenario
is consistent with findings that formation of long-lived antigen-independent memory T-cells is impaired
during chronic infection, and a strong active memory is only formed following acute infection [29].
Evolutionary branching
During this chronic phase, we also observe evolutionary branching corresponding to asexual speciation of
the pathogen population, which is fundamentally driven by the coevolutionary interaction between the
pathogens and the predatory immune response. This branching is visible in Fig. 2B and shown in more
detail in Fig. 1B.
As the immune response controls the pathogens, the decay caused by operation above homeostatic
equilibrium causes its density distribution in shape space to narrow, allowing pathogen strains to prolifer-
ate on the opposite side of the T-cell peak. This peak has higher affinity to the intermediate strains, and
eventually clears them, leaving two separated groups of pathogens which evolve away from the immune
response in opposite directions.
This speciation emerges as a direct result of the pathogen-immune interaction, without the typical
drivers of allopatry (i.e. spatial separation) or minima in the pathogen’s fitness landscape. The model’s
assumption that all pathogens and T-cells are well-mixed means that pathogen speciation is sympatric,
rather than the result of a varying spatial distribution within the population [19,20,30]. The underlying
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mechanism is the pathogen’s ability to survive in two distinct niches, which arise due to the disruptive
selection of the immune response on the phenotype continuum. Our results show a form of speciation
that results directly from an interaction between predator and prey, especially an interaction mediated
by a varying phenotypic trait.
For several hundred days after the pathogen split, the joint stimulation of the two strains maintains
a strong T-cell peak between them; however, eventually they separate enough for selection to favor two
distinct T-cell peaks over a single central one (Fig. 1C). The immune system’s enhanced control of the
pathogens here comes at the cost of approximately doubling the total T-cell density, causing T-cells
throughout shape space to experience increased homeostatic pressure.
Eventual immune escape
At each branching event, both total populations increase, peaking slightly as the T-cell population splits.
(This causes the cusps in total pathogen population in the inset in Fig. 3A.) The homeostatic pressure of
maintaining such a high-density immune response both impairs the ability of activated T-cells to maintain
control of existing pathogen strains, and causes increased susceptibility in the unactivated T-cell regions.
After almost 900 days of infection, this causes a dramatic immune escape (Fig. 1) in which the pathogens
grow out of control, spreading through the phenotypic space and proliferating to carrying capacity. Thus,
the pathogen speciation contributes to the weakening and eventual breakdown of the immune system.
This sudden increase in viral load after a long chronic period is reminiscent of the long-term qualitative
features of infections such as HIV and SIV [3,28,31] (Fig. 3A inset).
Discussion
Overall, our model provides a method of investigating patterns and behaviors in the coevolutionary
dynamics of the immune system, by abstracting the biochemical detail of the T-cell-pathogen interaction
and representing it on a low-dimensional phenotypic shape space. With simple choices for the relations
between binding shape, fitness, and relative mutation rates, the results reproduce the overall qualitative
behavior of well-known chronic infections such as HIV and SIV.
Although the true shape space of binding phenotypes is likely not one-dimensional [32], sequences of
preferred or coordinated mutations [33] may effectively reduce its dimension, making our choice a rea-
sonable approximation for many infections. However, a one-dimensional space does render independently
evolving pathogen strains more likely to encounter each other again through antigenic drift. When this
occurs, the overlap of stimulation regions incites a strong T-cell response between strains, as seen in
Fig. 1 around day 700. This ensures that convergent evolution does not occur even in a one-dimensional
shape space; the independent strains persist unless cleared by the immune response. However, interesting
questions remain about the specifics of the model’s behavior in higher-dimensional shape spaces, as well
as the effect of making disease-specific assumptions about the fitnesses and mutation rates of particular
pathogen strains.
The question of the T-cell binding specificity needed to mount the most effective response has been
the subject of much discussion and study [2,15,16]. Our results display a trade-off in na¨ıve cell specificity
(Fig. 4) that arises from a resource constraint, suggesting that the immune system’s strategy for managing
its limited resources could play an important role in its ability to control to a rapidly mutating infection.
Another often-discussed reason for specificity trade-offs in na¨ıve T-cells is the necessity of avoiding self-
reactivity [2], an effect not included in this model.
Evolutionary branching in similar predator-prey systems has been studied using the framework of
adaptive dynamics (e.g. [19,30,34]). Like the shape space technique, these models represent populations
on a phenotypic space, avoiding the complexity of high-dimensional models that track evolution at a
genetic level. In these models, evolutionary branching occurs at a fitness minimum which is usually built
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into the model or dependent on interactions of the branching population with its environment. The
branching in our model occurs at an effective pathogen fitness minimum created solely by the presence
of predatory immune response, since the fitness landscape independent of the immune system is flat.
The branching we see is thus driven by the coevolutionary interaction, and the exact point of branching
depends on these dynamics.
The increased immune system fragility observed during a chronic infection under homeostatic pressure,
in which the immune system is highly specialized to control the existing pathogen strains at the cost of
much lower protection in the unactivated regions, is typical of many complex systems displaying Highly
Optimized Tolerance [17, 35–37]. It leads to a state in which infection in new areas can proliferate
with little control by adaptive immunity. This causes the suddenly increased viral load similar to that
associated with the onset of AIDS [3,28], and the failure of immune system control.
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Appendix S1. Estimation and discussion of parameter values.
This Appendix provides biological details and discussion on parameter choices used in this model. To
obtain insight into the co-evolutionary dynamics of rapidly mutating pathogens and the adaptive immune
response, we choose biologically relevant values for these parameters (given in Table 1 in the main text),
drawing from previously measured and modeled characteristics of T-cells and well-studied viruses.
The parameter values shown in Table S1 are adopted or slightly modified from a previously published
shape space model of T-cell dynamics [14] or a related model of thymic T-cell influx during chronic
infection [8], in order to reproduce the basic acute infection immune system dynamics seen in these models.
The rate of pathogen growth λ is consistent with [14], and similar to previously measured values of the
initial expansion rate of HIV-1 [38, 39]. The rate of pathogen killing by the immune response has been
estimated to be between 0.1 and 0.5 day−1 near the peak of viremia in HIV and SIV infections [40, 41].
The concentration of virus-specific T-cells responding to the primary infection near this peak can be
roughly approximated as 104 µl−1, based on measurements of the CD8 T-cell response to an infection of
lymphocytic choriomeningitis virus (LCMV) in the mouse spleen [42,43]). Given these estimates, a value
on the order of 10−5 µl · day−1, as used in [14] and [8], is reasonable for a pathogen killing rate per day,
per concentration unit of T-cells in the adaptive response.
The T-cell replication and decay rates used here (denoted σ and δ, respectively) are consistent with
those estimated from measurements of the immune response to LCMV in mice (replication rates between
1 and 3 day−1, decay rates between 0.3 and 0.5 day−1) [43,44]. An approximate stimulation coecient κ is
given by early-stage HIV data in [45], in which the significant T-cell response is observed to begin when
viremia is on the order of 105 µl−1.
From a previous shape space modeling paper [14], we adopt an initial na¨ıve T-cell concentration L0
of 3 µl−1 for each shape space site (T-cell clone). This is a biologically reasonable value with typical
overall na¨ıve T-cell concentrations. We can then estimate Γ, the na¨ıve cell inux at a single shape space
site (T-cell clone), from the initial equilibrium condition in the absence of pathogen, given in Eq. 10 in
the main text: setting L0 = Γ/δ gives an approximate value of Γ = 1 (µl · site · day)−1. We chose a value
of φ = 1010 µl−1 for the pathogen carrying capacity in order to give acute infection dynamics comparable
to those in [45] and [14].
Table S1. Parameters adopted from previously published models [8, 14], and consistent with several
measurement and estimation studies on immune system and virus properties (see text).
Parameter Sym. Value
pathogen growth λ 3 day−1
pathogen killing β 10−5 µl · day−1
na¨ıve cell influx Γ 1 (µl · site · day)−1
T-cell replication σ 3 day−1
T-cell decay δ 0.33 day−1
stimulation coefficient κ 105 µl−1
We express mutation in terms of the overall mutation rate µ of the pathogens, in the commonly
used units of substitutions per DNA base per replication cycle. Each epitope has on the order of 10
amino acids, for an estimate of about 30 base pairs; thus, under the assumption that all base pairs in
the pathogen genome mutate independently at identical rates, we approximate the expected number of
mutations per cycle for a given epitope ~x as
µ′(~x) ≈ 30µ. (13)
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Consequently, if every member of a population of P identical epitopes replicates once, we will have
P × 30µ mutants. In terms of our model, then, µ′(~x) can be interpreted as the fraction of pathogens at
location ~x that differentiate to locations ~x′ 6= ~x, determined by the normalized mutation kernel Q and
the simulation space size n:
µ′(~x) =
∑
~x′ 6=~x
Q(~x, ~x′) = χ
(
2
pi
) 1
2 ∑
~x′ 6=~x
|~x− ~x′|−2. (14)
Here, the sum is performed over all n − 1 sites ~x′ that are not equal to ~x. For our chosen kernel Q, as
given in Eq. 7 in the main text of the paper, and n = 400, µ′ is nearly constant across the simulation
space (i.e., < µ′(~x) >≈ µ′(~x), ∀ ~x), so we set its average value equal to our approximation in Eq. 13:
< µ′(~x) >=
χ
n
(
2
pi
) 1
2 ∑
~x
∑
~x′ 6=~x
|~x− ~x′|−2 ≈ 30µ. (15)
Thus, having chosen Q and n, the value of the parameter χ is uniquely determined from µ. In this study,
we use the standard value µ = 2.2 × 10−5 substitutions per base pair per cycle, similar to commonly
measured values for the rapidly mutating virus HIV-1 [46], and study the effects of variation between
1 × 10−5 and 5 × 10−5. The binding specificity parameter b gives the width of the Gaussian affinity
curve in shape space, setting the specificity of the na¨ıve T-cell response. We choose b to correspond to
typical values of the precursor frequency, or the probability of two different na¨ıve T-cells responding to
the same epitope (about 1/105 [2,47]). Starting from the uniformly distributed initial condition in which
L(~y) = Γ/δ ∀ ~y (Eq. 10 in the main text of the paper), the number of na¨ıve T-cells under the affinity curve
centered at some ~y0, and thus cross-reactive with the response to a pathogen maximally complementary
to ~y0, is given in one dimension by
Γ
δ
∫
γ(~y, ~y0) d~y =
Γ
δ
∫
exp
[
−|~y − ~y0|
2
2b2
]
d~y =
bΓ
√
2pi
δ
. (16)
Although we only simulate a small portion of the full shape space for computational efficiency, the total
number of T-cells in our system is approximated by the initial na¨ıve density times the total number of
clones in the human immune system, with reasonable values between 106 − 107 [2]. To estimate b, we
can then set the fraction of cross-reactive na¨ıve T-cells equal to the precursor frequency:
b
√
2pi/(5× 106) = 10−5 −→ b ≈ 20. (17)
In this paper, we investigate values of b corresponding to the above range of total na¨ıve T-cell clones in
the system.
We investigated the system under several values of ξ, which controls the strength of the damping
homeostatic pressure. We chose values small enough that ξ << σR/|Ltot −R| and ξ << δR/|Ltot −R|,
so that the homeostatic pressure would not significantly alter the expected chronic infection steady-state
levels. In the main text of the paper we present results obtained at two different values of ξ. The higher
value (Fig. 5 in main text) shows much stronger damping of total population density oscillations in acute
infection, and converges to approximate chronic equilibrium quickly. Infections at the lower value of ξ
(Fig. 4 in main text) take longer to converge to a chronic infection, branch, and eventually escape control.
The branching and escape behaviors are observed consistently during chronic infections across values of
ξ, and appear to be driven by the same mechanisms, although the timescale on which they occur changes,
as well as the precise values of other parameters needed to generate a chronic infection.
In order to ensure that our choice to simulate only a limited region of the total shape space of na¨ıve
T-cell clones does not substantially affect our results, we investigated the behavior of several infections
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in a shape space with a substantially larger T-cell population (between 106 − 107 na¨ıve clones). We
found that extending the shape space in this way is effectively the same as lowering the parameter ξ: as
discussed in the main text, the timescales of convergence to chronic infection, branching, and eventual
immune escape are lengthened in a large shape space, while the overall effectiveness of the immune system
is enhanced. However, the mechanisms leading to chronic infection, branching, and eventual pathogen
escape are similar, though occurring on different timescales. In the main text and figures, we thus focus
on presenting results from a small portion of shape space for computational efficiency and more effective
visualization.
